Aprogen Medicines Inc.

₩1,720As of Sun 8 Nov 2026, 12:00 UTC
KRX:007460Industrials
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR (34.23%)
Div yield —
ROE (30.36%)
Conglomerates
Beta (5Y) 0.04
PE TTM —
TSR TTM (80.23%)
Mkt cap ₩38.20B
ROIC (14.23%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩1,812
5.34%
(78.31%)
Hold 0|1|8|11|1
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
20.20
19.72
21.04
22.75
14.68%
8.35%
9.68%
23.75%
Revenue₩B
2.481
2.582
2.520
2.563
1.24%
8.35%
7.67%
9.44%
Peers (US$28.17M)
Cap (US$)
PE
56.86M
65.20x
27.94M
8.825x
Capital
TTM
5Y
10Y
Leveragex
2.063
0.996
0.994
EBIT/Intx
0.642
0.147
0.144
Own earn%
54.19
7.64
1.92
Sh yield%
24.90
27.66
30.23
Owners
Insiders/Inst%
1.69
37.23
Short interest%
2.92
SBC / revenue%
3.42
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
25
Op margin range%
10–20
$1 testx
—
Incr. ROIC%
1